Meribank Biotech Co., Ltd (TPEX:4724)
Taiwan
· Delayed Price · Currency is TWD 16.60
-0.40 (-2.35%)
Jun 26, 2025, 1:43 PM CST
Meribank Biotech Revenue
In the year 2024, Meribank Biotech had annual revenue of 366.43M TWD with 56.37% growth. Meribank Biotech had revenue of 236.10M in the half year ending December 31, 2024, with 132.72% growth.
Revenue
366.43M
Revenue Growth
+56.37%
P/S Ratio
4.07
Revenue / Employee
2.58M
Employees
142
Market Cap
1.49B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 366.43M | 132.09M | 56.37% |
| Dec 31, 2023 | 234.34M | 54.22M | 30.10% |
| Dec 31, 2022 | 180.12M | 17.04M | 10.45% |
| Dec 31, 2021 | 163.08M | -31.32M | -16.11% |
| Dec 31, 2020 | 194.39M | 33.44M | 20.78% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Caliway Biopharmaceuticals | 40.47M |
| PharmaEssentia | 11.34B |
| Bora Pharmaceuticals Co., LTD. | 20.87B |
| Lotus Pharmaceutical | 19.12B |
| Oneness Biotech | 117.33M |
| Polaris Group | 87.67M |
| Center Laboratories | 1.63B |
| Lumosa Therapeutics | 43.59M |